Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $113.93 million. The enterprise value is $84.42 million.
Important Dates
The last earnings date was Friday, May 9, 2025, before market open.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PLX has 78.03 million shares outstanding. The number of shares has decreased by -5.05% in one year.
Current Share Class | 78.03M |
Shares Outstanding | 78.03M |
Shares Change (YoY) | -5.05% |
Shares Change (QoQ) | -26.56% |
Owned by Insiders (%) | 10.71% |
Owned by Institutions (%) | 7.02% |
Float | 59.15M |
Valuation Ratios
The trailing PE ratio is 33.97 and the forward PE ratio is 2.70.
PE Ratio | 33.97 |
Forward PE | 2.70 |
PS Ratio | 1.79 |
Forward PS | 1.64 |
PB Ratio | 2.57 |
P/TBV Ratio | 2.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 21.60 |
EV / Sales | 1.41 |
EV / EBITDA | 14.17 |
EV / EBIT | 18.24 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.12.
Current Ratio | 2.49 |
Quick Ratio | 1.62 |
Debt / Equity | 0.12 |
Debt / EBITDA | 0.69 |
Debt / FCF | n/a |
Interest Coverage | 6.83 |
Financial Efficiency
Return on equity (ROE) is 10.42% and return on invested capital (ROIC) is 5.43%.
Return on Equity (ROE) | 10.42% |
Return on Assets (ROA) | 3.53% |
Return on Invested Capital (ROIC) | 5.43% |
Return on Capital Employed (ROCE) | 9.34% |
Revenue Per Employee | $280,582 |
Profits Per Employee | $18,347 |
Employee Count | 213 |
Asset Turnover | 0.73 |
Inventory Turnover | 1.43 |
Taxes
In the past 12 months, PLX has paid $1.25 million in taxes.
Income Tax | 1.25M |
Effective Tax Rate | 24.19% |
Stock Price Statistics
The stock price has increased by +32.73% in the last 52 weeks. The beta is -0.05, so PLX's price volatility has been lower than the market average.
Beta (5Y) | -0.05 |
52-Week Price Change | +32.73% |
50-Day Moving Average | 2.51 |
200-Day Moving Average | 1.79 |
Relative Strength Index (RSI) | 24.19 |
Average Volume (20 Days) | 1,302,819 |
Short Selling Information
The latest short interest is 740,272, so 0.95% of the outstanding shares have been sold short.
Short Interest | 740,272 |
Short Previous Month | 650,638 |
Short % of Shares Out | 0.95% |
Short % of Float | 1.25% |
Short Ratio (days to cover) | 1.02 |
Income Statement
In the last 12 months, PLX had revenue of $59.76 million and earned $3.91 million in profits. Earnings per share was $0.04.
Revenue | 59.76M |
Gross Profit | 29.87M |
Operating Income | 4.63M |
Pretax Income | 6.77M |
Net Income | 3.91M |
EBITDA | 5.96M |
EBIT | 4.63M |
Earnings Per Share (EPS) | $0.04 |
Full Income Statement Balance Sheet
The company has $34.74 million in cash and $5.24 million in debt, giving a net cash position of $29.51 million or $0.38 per share.
Cash & Cash Equivalents | 34.74M |
Total Debt | 5.24M |
Net Cash | 29.51M |
Net Cash Per Share | $0.38 |
Equity (Book Value) | 45.21M |
Book Value Per Share | 0.57 |
Working Capital | 36.19M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$572,000 and capital expenditures -$990,000, giving a free cash flow of -$1.56 million.
Operating Cash Flow | -572,000 |
Capital Expenditures | -990,000 |
Free Cash Flow | -1.56M |
FCF Per Share | -$0.02 |
Full Cash Flow Statement Margins
Gross margin is 49.97%, with operating and profit margins of 7.74% and 6.54%.
Gross Margin | 49.97% |
Operating Margin | 7.74% |
Pretax Margin | 8.63% |
Profit Margin | 6.54% |
EBITDA Margin | 9.97% |
EBIT Margin | 7.74% |
FCF Margin | n/a |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 5.05% |
Shareholder Yield | 5.05% |
Earnings Yield | 3.43% |
FCF Yield | -1.37% |
Analyst Forecast
The average price target for PLX is $15.00, which is 927.40% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $15.00 |
Price Target Difference | 927.40% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Dec 20, 2019 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |